FIVE PRIME THERAPEUTICS INC's ticker is and the CUSIP is 33830X904. A total of 3 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | -100.0% | 163 | +75.3% | 0.00% | – |
| Q4 2020 | $158,000 | +777.8% | 93 | +138.5% | 0.00% | – |
| Q3 2020 | $18,000 | -83.5% | 39 | -78.3% | 0.00% | – |
| Q2 2020 | $109,000 | +303.7% | 180 | +47.5% | 0.00% | – |
| Q1 2020 | $27,000 | +575.0% | 122 | +1255.6% | 0.00% | – |
| Q4 2019 | $4,000 | – | 9 | +800.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 1 | -66.7% | 0.00% | – |
| Q2 2019 | $1,000 | -98.7% | 3 | -94.7% | 0.00% | – |
| Q1 2019 | $76,000 | +171.4% | 57 | +83.9% | 0.00% | – |
| Q4 2018 | $28,000 | -49.1% | 31 | -22.5% | 0.00% | – |
| Q3 2018 | $55,000 | +66.7% | 40 | +90.5% | 0.00% | – |
| Q2 2018 | $33,000 | – | 21 | +200.0% | 0.00% | – |
| Q1 2018 | $0 | – | 7 | +133.3% | 0.00% | – |
| Q4 2017 | $0 | – | 3 | +200.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | -83.3% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 6 | -88.5% | 0.00% | – |
| Q1 2017 | $9,000 | – | 52 | +2500.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 2 | -91.7% | 0.00% | -100.0% |
| Q1 2016 | $16,000 | +77.8% | 24 | +166.7% | 0.00% | 0.0% |
| Q4 2015 | $9,000 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 14,900 | $253,000 | 0.00% |
| SIMPLEX TRADING, LLC | 93 | $158,000 | 0.00% |